Estrogen and Progestin (Oral Contraceptives)

Oral contraceptives (birth-control pills) are used to prevent pregnancy. Estrogen and progestin are two female sex hormones. Combinations of estrogen and progestin work by preventing ovulation (the release of eggs from the ovaries). They also change the lining of the uterus (womb) to prevent pregnancy from developing and change the mucus at the cervix (opening of the uterus) to prevent sperm (male reproductive cells) from entering. Oral contraceptives are a very effective method of birth control, but they do not prevent the spread of human immunodeficiency virus (HIV, the virus that causes acquired immunodeficiency syndrome [AIDS]) and other sexually transmitted diseases.

Some brands of oral contraceptives are also used to treat acne in certain patients. Oral contraceptives treat acne by decreasing the amounts of certain natural substances that can cause acne.

Some oral contraceptives (Beyaz, Yaz) are also used to relieve the symptoms of premenstrual dysphoric disorder (physical and emotional symptoms that occur before the menstrual period each month) in women who have chosen to use an oral contraceptive to prevent pregnancy.

Oral contraceptives come in packets of 21, 28, or 91 tablets to take by mouth once a day, every day or almost every day of a regular cycle. To avoid nausea, take oral contraceptives with food or milk. Take your oral contraceptive at the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take your oral contraceptive exactly as directed. Do not take more or less of it, take it more often, or take it for a longer time than prescribed by your doctor.

Oral contraceptives come in many different brands. Different brands of oral contraceptives contain slightly different medications or doses, are taken in slightly different ways, and have different risks and benefits. Be sure that you know which brand of oral contraceptives you are using and exactly how you should use it. Ask your doctor or pharmacist for a copy of the manufacturer's information for the patient and read it carefully.

If you have a 21-tablet packet, take 1 tablet daily for 21 days and then none for 7 days. Then start a new packet.

If you have a 28-tablet packet, take 1 tablet daily for 28 days in a row in the order specified in your packet. Start a new packet the day after you take your 28th tablet. The tablets in most 28-tablet packets may have different colors. Many 28-tablet packets have certain color tablets that contain different amounts of estrogen and progestin, but also may have other color tablets which contain an inactive ingredient or a folate supplement.

If you have a 91-day tablet packet, take 1 tablet daily for 91 days. Your packet will contain three trays of tablets. Start with the first tablet on the first tray and continue taking 1 tablet every day in the order specified on the packet until you have taken all of the tablets on all of the trays. The last set of tablets are a different color. These tablets may contain an inactive ingredient, or they may contain a very low dose of estrogen. Start your new packet the day after you take your 91st tablet.

Your doctor will tell you when you should start taking your oral contraceptive. Oral contraceptives are usually started on the first or fifth day of your menstrual period or on the first Sunday after or on which bleeding begins. Your doctor will also tell you whether you need to use another method of birth control during the first 7 to 9 days that you take your oral contraceptive and will help you choose a method. Follow these directions carefully.

You will probably experience withdrawal bleeding similar to a menstrual period while you are taking the inactive tablets or the low dose estrogen tablets or during the week that you do not take your oral contraceptive. If you are taking the type of packet that only contains active tablets, you will not experience any scheduled bleeding, but you may experience unexpected bleeding and spotting, especially at the beginning of your treatment. Be sure to start taking your new packet on schedule even if you are still bleeding.

You may need to use a backup method of birth control if you vomit or have diarrhea while you are taking an oral contraceptive. Talk to your doctor about this before you begin to take your oral contraceptive so that you can prepare a backup method of birth control in case it is needed. If you vomit or have diarrhea while you are taking an oral contraceptive, call your doctor to find out how long you should use the backup method.

If you have recently given birth, wait until 4 weeks after delivery to begin taking oral contraceptives. If you have had an abortion or miscarriage, talk to your doctor about when you should begin taking oral contraceptives.

Oral contraceptives will work only as long as they are taken regularly. Continue to take oral contraceptives every day even if you are spotting or bleeding, have an upset stomach, or do not think that you are likely to become pregnant. Do not stop taking oral contraceptives without talking to your doctor.

Oral contraceptives are also sometimes used to treat heavy or irregular menstruation and endometriosis (a condition in which the type of tissue that lines the uterus [womb] grows in other areas of the body and causes pain, heavy or irregular menstruation [periods], and other symptoms). Talk to your doctor about the risks of using this medication for your condition.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking oral contraceptives,

• tell your doctor and pharmacist if you are allergic to estrogen, progestin, or any other medications.

• tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, and nutritional supplements you are taking. Be sure to mention any of the following: acetaminophen (APAP, Tylenol); antibiotics such as ampicillin (Principen), clarithromycin (Biaxin),erythromycin (E.E.S., E-Mycin, Erythrocin), isoniazid (INH, Nydrazid), metronidazole (Flagyl),minocycline (Dynacin, Minocin), rifabutin (Mycobutin), rifampin (Rifadin, Rimactane), tetracycline (Sumycin), and troleandomycin (TAO) (not available in the U.S.); anticoagulants ('blood thinners') such as warfarin (Coumadin); antifungals such as griseofulvin (Fulvicin, Grifulvin, Grisactin), fluconazole (Diflucan), itraconazole (Sporanox), and ketoconazole (Nizoral); atorvastatin (Lipitor); clofibrate (Atromid-S); cyclosporine (Neoral, Sandimmune); bosentan (Tracleer); cimetidine (Tagamet); danazol (Danocrine); delavirdine (Rescriptor); diltiazem (Cardizem, Dilacor, Tiazac); fluoxetine (Prozac, Sarafem, in Symbyax); HIV protease inhibitors such as indinavir (Crixivan) and ritonavir (Norvir); medications for seizures such as carbamazepine (Tegretol), felbamate (Felbatol), lamotrigine (Lamictal), oxcarbazepine (Trileptal), phenobarbital (Luminal, Solfoton), phenytoin (Dilantin), primidone (Mysoline), and topiramate (Topamax); modafinil (Provigil); morphine (Kadian, MS Contin, MSIR, others); nefazodone; rifampin (Rimactane, in Rifadin, in Rifater); oral steroids such as dexamethasone (Decadron, Dexone), methylprednisolone (Medrol), prednisone (Deltasone), and prednisolone (Prelone); temazepam (Restoril); theophylline (Theobid, Theo-Dur); thyroid medication such as levothyroxine (Levothroid, Levoxyl, Synthroid); verapamil (Calan, Covera, Isoptin, Verelan); vitamin C; and zafirlukast (Accolate). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

• if you are taking oral contraceptives that contain drosperinone (Beyaz, Gianvi, Loryna, Ocella, Safyral, Syeda, Yasmin, Yaz, and Zarah) tell your doctor and pharmacist if you are taking any of the medications listed above or any of the following: angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin), enalapril (Vasotec), and lisinopril (Prinivil, Zestril); angiotensin II antagonists such as irbesartan (Avapro), losartan (Cozaar), and valsartan (Diovan); aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); diuretics ('water pills') such as amiloride (Midamor), spironolactone (Aldactone), and triamterene (Dyrenium); eplerenone (Inspra); heparin; or potassium supplements. Before taking Beyaz or Safyral, also tell your doctor or pharmacist if you are taking cholestyramine (Locholest, Prevalite, Questran), a folate supplement, methotrexate (Trexall), pyrimethamine (Daraprim), sulfasalazine (Azulfidine), or valproic acid (Depakene, Stavzor).

• tell your doctor what herbal products you are taking, especially St. John's wort.

• tell your doctor if you have or have ever had blood clots in your legs, lungs, or eyes; thrombophilia (condition in which the blood clots easily); coronary artery disease (clogged blood vessels leading to the heart); cerebrovascular disease (clogging or weakening of the blood vessels within the brain or leading to the brain); stroke or mini-stroke; an irregular heartbeat; heart disease; a heart attack; chest pain; diabetes that has affected your circulation; headaches that come along with other symptoms such as vision changes, weakness, and dizziness; high blood pressure; breast cancer; cancer of the lining of the uterus, cervix, or vagina; liver cancer, liver tumors, or other types of liver disease; yellowing of the skin or eyes during pregnancy or while you were using hormonal contraceptives (birth control pills, patches, rings, implants, or injections); unexplained abnormal vaginal bleeding; adrenal insufficiency (condition in which the body does not produce enough of certain natural substances needed for important functions such as blood pressure); or kidney disease. Also tell your doctor if you have recently had surgery or have been unable to move around for any reason. Your doctor may tell you that you should not take certain types of oral contraceptives or that you should not take any type of oral contraceptive if you have or have had any of these conditions.

• Also tell your doctor if anyone in your family has had breast cancer, if you are overweight, and if you have or have ever had problems with your breasts such as lumps, an abnormal mammogram (breast x-ray), or fibrocystic breast disease (swollen, tender breasts and/or breast lumps that are not cancer); high blood cholesterol or fats; diabetes; asthma; toxemia (high blood pressure during pregnancy); heart attack; chest pain; seizures; migraine headaches; depression; gallbladder disease; jaundice (yellowing of the skin or eyes); and excessive weight gain and fluid retention (bloating) during the menstrual cycle.

• do not take oral contraceptives if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking oral contraceptives, call your doctor immediately.

• if you miss periods while you are taking oral contraceptives, you may be pregnant. If you are using a 91-tablet packet and you miss one period, call your doctor. If you are using another type of packet according to the directions and you miss one period, you may continue to take your tablets. However, if you have not taken your tablets as directed and you miss one period or if you have taken your tablets as directed and you miss two periods, call your doctor and use another method of birth control until you have a pregnancy test. If you are using a 28-tablet packet that contains only active tablets, you will not expect to have periods on a regular basis, so it may be hard to tell if you are pregnant. If you are using this type of oral contraceptive, call your doctor and have a pregnancy test if you experience symptoms of pregnancy such as nausea, vomiting, and breast tenderness, or if you suspect you may be pregnant.

• if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking oral contraceptives.

• you should know that oral contraceptives may cause a spotty darkening of the skin, especially on the face. If you have experienced changes in your skin color during pregnancy or while you were taking oral contraceptives in the past, you should avoid exposure to real or artificial sunlight while you are taking oral contraceptives. Wear protective clothing, sunglasses, and sunscreen.

• tell your doctor and pharmacist if you wear contact lenses. If you notice changes in vision or ability to wear your lenses while taking oral contraceptives, see an eye doctor.

Unless your doctor tells you otherwise, continue your normal diet.

If you miss doses of your oral contraceptive, you may not be protected from pregnancy. You may need to use a backup method of birth control for 7 to 9 days or until the end of the cycle. Every brand of oral contraceptives comes with specific directions to follow if you miss one or more doses. Carefully read the directions in the manufacturer's information for the patient that came with your oral contraceptive. If you have any questions, call your doctor or pharmacist. Continue to take your tablets as scheduled and use a backup method of birth control until your questions are answered.

• Oral contraceptives may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • nausea

  • vomiting

  • stomach cramps or bloating

  • diarrhea

  • constipation

  • gingivitis (swelling of the gum tissue)

  • increased or decreased appetite

  • weight gain or weight loss

  • brown or black skin patches

  • acne

  • hair growth in unusual places

  • bleeding or spotting between menstrual periods

  • changes in menstrual flow

  • painful or missed periods

  • breast tenderness, enlargement, or discharge

  • swelling, redness, irritation, burning, or itching of the vagina

  • white vaginal discharge

• Some side effects can be serious. The following symptoms are uncommon, but if you experience any of them, call your doctor immediately:

  • severe headache

  • severe vomiting

  • speech problems

  • dizziness or faintness

  • weakness or numbness of an arm or leg

  • crushing chest pain or chest heaviness

  • coughing up blood

  • shortness of breath

  • leg pain

  • partial or complete loss of vision

  • double vision

  • bulging eyes

  • severe stomach pain

  • yellowing of the skin or eyes

  • loss of appetite

  • extreme tiredness, weakness, or lack of energy

  • fever

  • dark-colored urine

  • light-colored stool

  • swelling of the hands, feet, ankles, or lower legs

  • depression, especially if you also have trouble sleeping, tiredness, loss of energy, or other mood changes

  • unusual bleeding

  • rash

  • menstrual bleeding that is unusually heavy or that lasts for longer than 7 days in a row

• Oral contraceptives may increase the chance that you will develop liver tumors. These tumors are not a form of cancer, but they can break and cause serious bleeding inside the body. Oral contraceptives may also increase the chance that you will develop breast or liver cancer, or have a heart attack, a stroke, or a serious blood clot. Talk to your doctor about the risks of using oral contraceptives.

• Some studies show that women who take oral contraceptives that contain drosperinone (Beyaz, Gianvi, Loryna, Ocella, Safyral, Syeda, Yasmin, Yaz, and Zarah) may be more likely to develop deep vein thrombosis (a serious or life-threatening condition in which blood clots that form in the veins, usually in the legs and may move through the body to the lungs) than women who take oral contraceptives that do not contain drosperinone. However, other studies do not show this increased risk. Before you begin taking oral contraceptives, talk to your doctor about the risk that you will develop blood clots and about which oral contraceptive or other method of birth control may be the best choice for you.

• Oral contraceptives may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

• If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the packet it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

• nausea

• vaginal bleeding

Keep all appointments with your doctor and the laboratory. You should have a complete physical examination every year, including blood pressure measurements, breast and pelvic exams, and a Pap test. Follow your doctor's directions for examining your breasts; report any lumps immediately.

Before you have any laboratory tests, tell the laboratory personnel that you take oral contraceptives.

If you wish to stop taking oral contraceptives and become pregnant, your doctor may tell you to use another method of birth control until you begin to menstruate regularly again. It may take a long time for you to become pregnant after you stop taking oral contraceptives, especially if you have never had a baby or if you had irregular, infrequent, or complete absence of menstrual periods before taking oral contraceptives. However, it is possible to become pregnant within days of stopping certain oral contraceptives. If you want to stop taking oral contraceptives but do not want to become pregnant, you should begin using another type of birth control as soon as you stop taking oral contraceptives. Discuss any questions that you may have with your doctor.

Oral contraceptives may decrease the amount of folate in your body. Folate is important for the development of a healthy baby, so you should talk to your doctor if you want to become pregnant soon after you stop taking oral contraceptives. Your doctor may recommend that you take a folate supplement or an oral contraceptive that contains a folate supplement (Beyaz, Safyral).

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

• Apri^® (containing Desogestrel, Ethinyl Estradiol)
• Aranelle^® (containing Ethinyl Estradiol, Norethindrone)
• Aviane^® (containing Ethinyl Estradiol, Levonorgestrel)
• Azurette^® (containing Desogestrel, Ethinyl Estradiol)
• Balziva^® (containing Ethinyl Estradiol, Norethindrone)
• Beyaz^® (containing Drospirenone, Ethinyl Estradiol, Levomefolate)
• Brevicon^® (containing Ethinyl Estradiol, Norethindrone)
• Camrese Lo^® (containing Ethinyl Estradiol, Levonorgestrel)
• Camrese^® (containing Ethinyl Estradiol, Levonorgestrel)
• Cesia^® (containing Desogestrel, Ethinyl Estradiol)
• Cryselle^® (containing Ethinyl Estradiol, Norgestrel)
• Cyclessa^® (containing Desogestrel, Ethinyl Estradiol)
• Demulen^® (containing Ethynodiol, Ethinyl Estradiol)
• Desogen^® (containing Desogestrel, Ethinyl Estradiol)
• Enpresse^® (containing Ethinyl Estradiol, Levonorgestrel)
• Estrostep^® Fe (containing Ethinyl Estradiol, Norethindrone)
• Femcon^® Fe (containing Ethinyl Estradiol, Norethindrone)
• Gianvi^® (containing Drospirenone, Ethinyl Estradiol)
• Jolessa^® (containing Ethinyl Estradiol, Levonorgestrel)
• Junel^® (containing Ethinyl Estradiol, Norethindrone)
• Junel^® Fe (containing Ethinyl Estradiol, Norethindrone)
• Kariva^® (containing Desogestrel, Ethinyl Estradiol)
• Kelnor^® (containing Ethynodiol, Ethinyl Estradiol)
• Leena^® (containing Ethinyl Estradiol, Norethindrone)
• Lessina^® (containing Ethinyl Estradiol, Levonorgestrel)
• Levlen^® (containing Ethinyl Estradiol, Levonorgestrel)
• Levlite^® (containing Ethinyl Estradiol, Levonorgestrel)
• Levora^® (containing Ethinyl Estradiol, Levonorgestrel)
• Lo/Ovral^® (containing Ethinyl Estradiol, Norgestrel)
• Loestrin^® (containing Ethinyl Estradiol, Norethindrone)
• Loestrin^® Fe (containing Ethinyl Estradiol, Norethindrone)
• Loryna^® (containing Drospirenone, Ethinyl Estradiol)
• LoSeasonique^® (containing Ethinyl Estradiol, Levonorgestrel)
• Low-Ogestrel^® (containing Ethinyl Estradiol, Norgestrel)
• Lutera^® (containing Ethinyl Estradiol, Levonorgestrel)
• Lybrel^® (containing Ethinyl Estradiol, Levonorgestrel)
• Microgestin^® (containing Ethinyl Estradiol, Norethindrone)
• Microgestin^® Fe (containing Ethinyl Estradiol, Norethindrone)
• Mircette^® (containing Desogestrel, Ethinyl Estradiol)
• Modicon^® (containing Ethinyl Estradiol, Norethindrone)
• MonoNessa^® (containing Ethinyl Estradiol, Norgestimate)
• Natazia^® (containing estradiol valerate and dienogest)
• Necon^® 0.5/35 (containing Ethinyl Estradiol, Norethindrone)
• Necon^® 1/50 (containing Mestranol, Norethindrone)
• Nordette^® (containing Ethinyl Estradiol, Levonorgestrel)
• Norinyl^® 1+35 (containing Ethinyl Estradiol, Norethindrone)
• Norinyl^® 1+50 (containing Mestranol, Norethindrone)
• Nortrel^® (containing Ethinyl Estradiol, Norethindrone)
• Ocella^® (containing Drospirenone, Ethinyl Estradiol)
• Ogestrel^® (containing Ethinyl Estradiol, Norgestrel)
• Ortho Tri-Cyclen^® (containing Ethinyl Estradiol, Norgestimate)
• Ortho Tri-Cyclen^® Lo (containing Ethinyl Estradiol, Norgestimate)
• Ortho-Cept^® (containing Desogestrel, Ethinyl Estradiol)
• Ortho-Cyclen^® (containing Ethinyl Estradiol, Norgestimate)
• Ortho-Novum^® 1/35 (containing Ethinyl Estradiol, Norethindrone)
• Ortho-Novum^® 1/50 [DSC] (containing Mestranol, Norethindrone)
• Ovcon^® (containing Ethinyl Estradiol, Norethindrone)
• Portia^® (containing Ethinyl Estradiol, Levonorgestrel)
• Previfem^® [DSC] (containing Ethinyl Estradiol, Norgestimate)
• Quasense^® (containing Ethinyl Estradiol, Levonorgestrel)
• Reclipsen^® (containing Desogestrel, Ethinyl Estradiol)
• Safyral^® (containing Drospirenone, Ethinyl Estradiol, Levomefolate)
• Seasonale^® (containing Ethinyl Estradiol, Levonorgestrel)
• Seasonique^® (containing Ethinyl Estradiol, Levonorgestrel)
• Solia^® (containing Desogestrel, Ethinyl Estradiol)
• Sprintec^® (containing Ethinyl Estradiol, Norgestimate)
• Sronyx^® (containing Ethinyl Estradiol, Levonorgestrel)
• Syeda^® (containing Drospirenone, Ethinyl Estradiol)
• Tilia^® Fe (containing Ethinyl Estradiol, Norethindrone)
• Tri-Legest^® Fe (containing Ethinyl Estradiol, Norethindrone)
• Tri-Norinyl^® (containing Ethinyl Estradiol, Norethindrone)
• Tri-Previfem^® [DSC] (containing Ethinyl Estradiol, Norgestimate)
• Tri-Sprintec^® (containing Ethinyl Estradiol, Norgestimate)
• TriNessa^® (containing Ethinyl Estradiol, Norgestimate)
• Triphasil^® (containing Ethinyl Estradiol, Levonorgestrel)
• Trivora^® (containing Ethinyl Estradiol, Levonorgestrel)
• Velivet^® (containing Desogestrel, Ethinyl Estradiol)
• Yasmin^® (containing Drospirenone, Ethinyl Estradiol)
• Yaz^® (containing Drospirenone, Ethinyl Estradiol)
• Zarah^® (containing Drospirenone, Ethinyl Estradiol)
• Zenchent^® (containing Ethinyl Estradiol, Norethindrone)
• Zeosa^® Fe (containing Ethinyl Estradiol, Norethindrone)
• Zovia^® (containing Ethynodiol, Ethinyl Estradiol)

• Birth-control pills

Drug	Interaction
Moxifloxacin	Moxifloxacin The metabolism of Conjugated estrogens can be decreased when combined with Moxifloxacin.
Repaglinide	Repaglinide The excretion of Repaglinide can be decreased when combined with Conjugated estrogens.
Insulin Glargine (rDNA origin) Injection	Insulin Glargine (rDNA origin) Injection The metabolism of Conjugated estrogens can be increased when combined with Insulin glargine.
Leflunomide	Leflunomide The serum concentration of Conjugated estrogens can be decreased when it is combined with Leflunomide.
Nevirapine	Nevirapine The metabolism of Conjugated estrogens can be decreased when combined with Nevirapine.
Atorvastatin	Atorvastatin The excretion of Atorvastatin can be decreased when combined with Conjugated estrogens.
Aminophylline	Aminophylline The metabolism of Aminophylline can be decreased when combined with Conjugated estrogens.
Anagrelide	Anagrelide The metabolism of Conjugated estrogens can be decreased when combined with Anagrelide.
Candesartan	Candesartan The excretion of Conjugated estrogens can be decreased when combined with Candesartan.
Cilostazol	Cilostazol The metabolism of Cilostazol can be decreased when combined with Conjugated estrogens.
Clopidogrel	Clopidogrel The metabolism of Clopidogrel can be decreased when combined with Conjugated estrogens.
Erythromycin and Sulfisoxazole	Erythromycin and Sulfisoxazole The excretion of Conjugated estrogens can be decreased when combined with Erythromycin.
Fenofibrate	Fenofibrate Conjugated estrogens may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine	Guanfacine Conjugated estrogens may decrease the excretion rate of Guanfacine which could result in a higher serum level.
Magnesium Hydroxide	Magnesium Hydroxide Conjugated estrogens may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Mycophenolate	Mycophenolate Conjugated estrogens may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Olsalazine	Olsalazine Olsalazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Potassium	Potassium Potassium may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone	Prednisone The serum concentration of Prednisone can be increased when it is combined with Conjugated estrogens.
Ranitidine	Ranitidine The excretion of Ranitidine can be decreased when combined with Conjugated estrogens.
Reserpine	Reserpine Reserpine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Rizatriptan	Rizatriptan Conjugated estrogens may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan	Sumatriptan Conjugated estrogens may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus	Tacrolimus Tacrolimus may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Tizanidine	Tizanidine The serum concentration of Tizanidine can be increased when it is combined with Conjugated estrogens.
Triamcinolone	Triamcinolone The serum concentration of Triamcinolone can be increased when it is combined with Conjugated estrogens.
Zolmitriptan	Zolmitriptan The metabolism of Zolmitriptan can be decreased when combined with Conjugated estrogens.
Ampicillin Injection	Ampicillin Injection Conjugated estrogens may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection	Doxycycline Injection Doxycycline may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Famotidine Injection	Famotidine Injection The excretion of Famotidine can be decreased when combined with Conjugated estrogens.
Fluconazole Injection	Fluconazole Injection Fluconazole may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Foscarnet Injection	Foscarnet Injection Foscarnet may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Hydromorphone Injection	Hydromorphone Injection Conjugated estrogens may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
Interferon Beta-1b Injection	Interferon Beta-1b Injection The metabolism of Conjugated estrogens can be decreased when combined with Interferon beta-1b.
Interferon Gamma-1b Injection	Interferon Gamma-1b Injection The metabolism of Conjugated estrogens can be decreased when combined with Interferon gamma-1b.
Levofloxacin Injection	Levofloxacin Injection The metabolism of Conjugated estrogens can be decreased when combined with Levofloxacin.
Meperidine Injection	Meperidine Injection The metabolism of Conjugated estrogens can be increased when combined with Meperidine.
Methylprednisolone Injection	Methylprednisolone Injection The serum concentration of Methylprednisolone can be increased when it is combined with Conjugated estrogens.
Metoclopramide Injection	Metoclopramide Injection The metabolism of Metoclopramide can be decreased when combined with Conjugated estrogens.
Pamidronate Injection	Pamidronate Injection Pamidronic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Vancomycin Injection	Vancomycin Injection Conjugated estrogens may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection	Zidovudine Injection The excretion of Zidovudine can be decreased when combined with Conjugated estrogens.
Altretamine	Altretamine Amphetamine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefuroxime	Cefuroxime Cefuroxime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cyclosporine	Cyclosporine Cyclosporine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ondansetron	Ondansetron The metabolism of Conjugated estrogens can be decreased when combined with Ondansetron.
Enoxaparin Injection	Enoxaparin Injection Conjugated estrogens may decrease the anticoagulant activities of Enoxaparin.
Torsemide	Torsemide Torasemide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine	Olanzapine The metabolism of Olanzapine can be decreased when combined with Conjugated estrogens.
Alosetron	Alosetron The metabolism of Conjugated estrogens can be decreased when combined with Alosetron.
Entacapone	Entacapone The metabolism of Conjugated estrogens can be decreased when combined with Entacapone.
Eprosartan	Eprosartan The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Eprosartan.
Meloxicam	Meloxicam Meloxicam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Pantoprazole	Pantoprazole The excretion of Conjugated estrogens can be decreased when combined with Pantoprazole.
Telmisartan	Telmisartan Telmisartan may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Temozolomide	Temozolomide Conjugated estrogens may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon	Zaleplon Conjugated estrogens may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Anakinra	Anakinra The metabolism of Conjugated estrogens can be increased when combined with Anakinra.
Pentosan Polysulfate	Pentosan Polysulfate Conjugated estrogens may decrease the anticoagulant activities of Pentosan polysulfate.
Trimipramine	Trimipramine The serum concentration of Trimipramine can be increased when it is combined with Conjugated estrogens.
Etanercept Injection	Etanercept Injection The metabolism of Conjugated estrogens can be increased when combined with Etanercept.
Modafinil	Modafinil The metabolism of Conjugated estrogens can be increased when combined with Armodafinil.
Perindopril	Perindopril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Perindopril.
Tenofovir	Tenofovir Tenofovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Choline Magnesium Trisalicylate	Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Sirolimus	Sirolimus The risk or severity of angioedema can be increased when Sirolimus is combined with Conjugated estrogens.
Eplerenone	Eplerenone Eplerenone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Zonisamide	Zonisamide Conjugated estrogens may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.
Adalimumab Injection	Adalimumab Injection The metabolism of Conjugated estrogens can be increased when combined with Adalimumab.
Atomoxetine	Atomoxetine Conjugated estrogens may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
Ezetimibe	Ezetimibe The excretion of Ezetimibe can be decreased when combined with Conjugated estrogens.
Atazanavir	Atazanavir Atazanavir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Almotriptan	Almotriptan Conjugated estrogens may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Omalizumab Injection	Omalizumab Injection Conjugated estrogens may increase the thrombogenic activities of Omalizumab.
Rosuvastatin	Rosuvastatin The excretion of Rosuvastatin can be decreased when combined with Conjugated estrogens.
Emtricitabine	Emtricitabine Conjugated estrogens may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Interferon Beta-1a Subcutaneous Injection	Interferon Beta-1a Subcutaneous Injection The metabolism of Conjugated estrogens can be decreased when combined with Interferon beta-1a.
Memantine	Memantine Conjugated estrogens may decrease the excretion rate of Memantine which could result in a higher serum level.
Tegaserod	Tegaserod The metabolism of Conjugated estrogens can be decreased when combined with Tegaserod.
Tadalafil	Tadalafil Conjugated estrogens may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Frovatriptan	Frovatriptan The metabolism of Frovatriptan can be decreased when combined with Conjugated estrogens.
Gemifloxacin	Gemifloxacin The metabolism of Conjugated estrogens can be decreased when combined with Gemifloxacin.
Progesterone	Progesterone Progesterone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Infliximab Injection	Infliximab Injection The metabolism of Conjugated estrogens can be increased when combined with Infliximab.
Protriptyline	Protriptyline The serum concentration of Protriptyline can be increased when it is combined with Conjugated estrogens.
Duloxetine	Duloxetine The metabolism of Duloxetine can be decreased when combined with Conjugated estrogens.
Tinidazole	Tinidazole Conjugated estrogens may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan	Bosentan The excretion of Bosentan can be decreased when combined with Conjugated estrogens.
Cefditoren	Cefditoren The excretion of Cefdinir can be decreased when combined with Conjugated estrogens.
Cinacalcet	Cinacalcet The metabolism of Cinacalcet can be decreased when combined with Conjugated estrogens.
Natalizumab Injection	Natalizumab Injection Conjugated estrogens may increase the thrombogenic activities of Natalizumab.
Cyanocobalamin Injection	Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Erlotinib	Erlotinib The metabolism of Conjugated estrogens can be decreased when combined with Erlotinib.
Eszopiclone	Eszopiclone Conjugated estrogens may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
Ganciclovir	Ganciclovir The excretion of Ganciclovir can be decreased when combined with Conjugated estrogens.
Ribavirin	Ribavirin Conjugated estrogens may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Valganciclovir	Valganciclovir Conjugated estrogens may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Adefovir	Adefovir Adefovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Dextroamphetamine	Dextroamphetamine Amphetamine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Entecavir	Entecavir The metabolism of Entecavir can be decreased when combined with Conjugated estrogens.
Peginterferon Alfa-2a Injection	Peginterferon Alfa-2a Injection The metabolism of Conjugated estrogens can be decreased when combined with Peginterferon alfa-2a.
Peginterferon Alfa-2b (PEG-Intron)	Peginterferon Alfa-2b (PEG-Intron) The serum concentration of Conjugated estrogens can be increased when it is combined with Peginterferon alfa-2b.
Ramelteon	Ramelteon The metabolism of Ramelteon can be decreased when combined with Conjugated estrogens.
Fentanyl	Fentanyl Conjugated estrogens may decrease the excretion rate of Fentanyl which could result in a higher serum level.
Pregabalin	Pregabalin The risk or severity of angioedema can be increased when Pregabalin is combined with Conjugated estrogens.
Deferasirox	Deferasirox The serum concentration of Conjugated estrogens can be increased when it is combined with Deferasirox.
Phenylephrine	Phenylephrine The metabolism of Conjugated estrogens can be increased when combined with Phenylephrine.
Tipranavir	Tipranavir The excretion of Conjugated estrogens can be decreased when combined with Tipranavir.
Ranolazine	Ranolazine Ranolazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Abatacept Injection	Abatacept Injection The metabolism of Conjugated estrogens can be increased when combined with Abatacept.
Rasagiline	Rasagiline The metabolism of Rasagiline can be decreased when combined with Conjugated estrogens.
Imatinib	Imatinib Imatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Sitagliptin	Sitagliptin The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Sitagliptin.
Varenicline	Varenicline Conjugated estrogens may decrease the excretion rate of Varenicline which could result in a higher serum level.
Bevacizumab Injection	Bevacizumab Injection Conjugated estrogens may increase the thrombogenic activities of Bevacizumab.
Gefitinib	Gefitinib Gefitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Albuterol	Albuterol Conjugated estrogens may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone	Paliperidone Conjugated estrogens may decrease the excretion rate of Paliperidone which could result in a higher serum level.
Exemestane	Exemestane The therapeutic efficacy of Exemestane can be decreased when used in combination with Conjugated estrogens.
Bortezomib	Bortezomib The metabolism of Bortezomib can be decreased when combined with Conjugated estrogens.
Clofarabine Injection	Clofarabine Injection The excretion of Clofarabine can be decreased when combined with Conjugated estrogens.
Insulin Glulisine (rDNA origin) Injection	Insulin Glulisine (rDNA origin) Injection The metabolism of Conjugated estrogens can be increased when combined with Insulin glulisine.
Lubiprostone	Lubiprostone Conjugated estrogens may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Primaquine	Primaquine The metabolism of Primaquine can be increased when combined with Conjugated estrogens.
Rituximab Injection	Rituximab Injection Conjugated estrogens may increase the thrombogenic activities of Rituximab.
Cetuximab Injection	Cetuximab Injection Conjugated estrogens may increase the thrombogenic activities of Cetuximab.
Darunavir	Darunavir The excretion of Conjugated estrogens can be decreased when combined with Darunavir.
Pemetrexed Injection	Pemetrexed Injection Conjugated estrogens may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Ranibizumab Injection	Ranibizumab Injection Conjugated estrogens may increase the thrombogenic activities of Ranibizumab.
Sorafenib	Sorafenib The metabolism of Conjugated estrogens can be decreased when combined with Sorafenib.
Sunitinib	Sunitinib Sunitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Dronabinol	Dronabinol Dronabinol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Levocetirizine	Levocetirizine Conjugated estrogens may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection	Pegaptanib Injection Conjugated estrogens may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib	Dasatinib The metabolism of Conjugated estrogens can be decreased when combined with Dasatinib.
Mexiletine	Mexiletine The metabolism of Conjugated estrogens can be decreased when combined with Mexiletine.
Panitumumab Injection	Panitumumab Injection Conjugated estrogens may increase the thrombogenic activities of Panitumumab.
Armodafinil	Armodafinil The metabolism of Conjugated estrogens can be increased when combined with Armodafinil.
Azacitidine Injection	Azacitidine Injection Conjugated estrogens may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Ivermectin	Ivermectin The excretion of Conjugated estrogens can be decreased when combined with Ivermectin.
Temsirolimus	Temsirolimus The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Temsirolimus.
Lenalidomide	Lenalidomide Conjugated estrogens may increase the thrombogenic activities of Lenalidomide.
Nilotinib	Nilotinib Nilotinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Budesonide	Budesonide The serum concentration of Budesonide can be increased when it is combined with Conjugated estrogens.
Desmopressin	Desmopressin Desmopressin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Doripenem Injection	Doripenem Injection The excretion of Doripenem can be decreased when combined with Conjugated estrogens.
Arsenic Trioxide Injection	Arsenic Trioxide Injection Conjugated estrogens may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine	Desvenlafaxine Conjugated estrogens may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
Cevimeline	Cevimeline Cevimeline may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Bendamustine Injection	Bendamustine Injection The metabolism of Bendamustine can be decreased when combined with Conjugated estrogens.
Leucovorin Injection	Leucovorin Injection The excretion of Leucovorin can be decreased when combined with Conjugated estrogens.
Flecainide	Flecainide The metabolism of Flecainide can be decreased when combined with Conjugated estrogens.
Certolizumab Injection	Certolizumab Injection The metabolism of Conjugated estrogens can be increased when combined with Certolizumab pegol.
Irinotecan Injection	Irinotecan Injection The excretion of Conjugated estrogens can be decreased when combined with Irinotecan.
Daptomycin Injection	Daptomycin Injection Daptomycin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Praziquantel	Praziquantel The metabolism of Praziquantel can be decreased when combined with Conjugated estrogens.
Methylnaltrexone Injection	Methylnaltrexone Injection Conjugated estrogens may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia)	Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Conjugated estrogens may increase the thrombogenic activities of Alemtuzumab.
Midazolam	Midazolam Conjugated estrogens may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dexrazoxane Injection	Dexrazoxane Injection Conjugated estrogens may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
Eltrombopag	Eltrombopag Eltrombopag may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ibritumomab Injection	Ibritumomab Injection Conjugated estrogens may increase the thrombogenic activities of Ibritumomab tiuxetan.
Milnacipran	Milnacipran Conjugated estrogens may decrease the excretion rate of Milnacipran which could result in a higher serum level.
Plerixafor Injection	Plerixafor Injection Conjugated estrogens may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine	Fesoterodine Conjugated estrogens may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Betaxolol	Betaxolol The metabolism of Conjugated estrogens can be decreased when combined with Betaxolol.
Prasugrel	Prasugrel Conjugated estrogens may decrease the anticoagulant activities of Prasugrel.
Everolimus	Everolimus The excretion of Conjugated estrogens can be decreased when combined with Everolimus.
Tolvaptan (low blood sodium)	Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone	Dronedarone The excretion of Conjugated estrogens can be decreased when combined with Dronedarone.
Pralatrexate Injection	Pralatrexate Injection Conjugated estrogens may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection	Palonosetron Injection Conjugated estrogens may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Saxagliptin	Saxagliptin The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Saxagliptin.
Telavancin Injection	Telavancin Injection Conjugated estrogens may decrease the excretion rate of Telavancin which could result in a higher serum level.
Topotecan	Topotecan Conjugated estrogens may decrease the excretion rate of Topotecan which could result in a higher serum level.
Ofatumumab Injection (Chronic Lymphocytic Leukemia)	Ofatumumab Injection (Chronic Lymphocytic Leukemia) Conjugated estrogens may increase the thrombogenic activities of Ofatumumab.
Golimumab Injection	Golimumab Injection The metabolism of Conjugated estrogens can be increased when combined with Golimumab.
Pazopanib	Pazopanib The metabolism of Pazopanib can be decreased when combined with Conjugated estrogens.
Asenapine	Asenapine The metabolism of Asenapine can be decreased when combined with Conjugated estrogens.
Pitavastatin	Pitavastatin The excretion of Pitavastatin can be decreased when combined with Conjugated estrogens.
Albendazole	Albendazole The metabolism of Albendazole can be decreased when combined with Conjugated estrogens.
Denosumab Injection	Denosumab Injection Conjugated estrogens may increase the thrombogenic activities of Denosumab.
Dabigatran	Dabigatran Conjugated estrogens may decrease the anticoagulant activities of Dabigatran.
Tocilizumab Injection	Tocilizumab Injection The metabolism of Conjugated estrogens can be increased when combined with Tocilizumab.
Dalfampridine	Dalfampridine Conjugated estrogens may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Cabazitaxel Injection	Cabazitaxel Injection Cabazitaxel may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ustekinumab Injection	Ustekinumab Injection Conjugated estrogens may increase the thrombogenic activities of Ustekinumab.
Ceftaroline Injection	Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Acetaminophen Injection	Acetaminophen Injection The metabolism of Acetaminophen can be decreased when combined with Conjugated estrogens.
Ipilimumab Injection	Ipilimumab Injection Conjugated estrogens may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection	Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Terbutaline Injection	Terbutaline Injection Conjugated estrogens may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Belimumab Injection	Belimumab Injection Conjugated estrogens may increase the thrombogenic activities of Belimumab.
Azilsartan	Azilsartan The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Azilsartan medoxomil.
Roflumilast	Roflumilast Conjugated estrogens may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Linagliptin	Linagliptin The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Linagliptin.
Rilpivirine	Rilpivirine Rilpivirine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Telaprevir	Telaprevir Glecaprevir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Abiraterone	Abiraterone The serum concentration of Conjugated estrogens can be increased when it is combined with Abiraterone.
Rivaroxaban	Rivaroxaban Conjugated estrogens may decrease the anticoagulant activities of Rivaroxaban.
Ticagrelor	Ticagrelor Conjugated estrogens may decrease the anticoagulant activities of Ticagrelor.
Brentuximab Vedotin Injection	Brentuximab Vedotin Injection Conjugated estrogens may increase the thrombogenic activities of Brentuximab vedotin.
Ruxolitinib	Ruxolitinib Conjugated estrogens may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Vandetanib	Vandetanib Vandetanib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Clobazam	Clobazam Conjugated estrogens may decrease the excretion rate of Clobazam which could result in a higher serum level.
Vemurafenib	Vemurafenib The serum concentration of Conjugated estrogens can be increased when it is combined with Vemurafenib.
Vismodegib	Vismodegib Vismodegib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Basiliximab Injection	Basiliximab Injection Conjugated estrogens may increase the thrombogenic activities of Basiliximab.
Deferiprone	Deferiprone Conjugated estrogens may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib	Axitinib The metabolism of Axitinib can be decreased when combined with Conjugated estrogens.
Naloxone Injection	Naloxone Injection Conjugated estrogens may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan	Ambrisentan The excretion of Ambrisentan can be decreased when combined with Conjugated estrogens.
Eculizumab Injection	Eculizumab Injection Conjugated estrogens may increase the thrombogenic activities of Eculizumab.
Fondaparinux Injection	Fondaparinux Injection Conjugated estrogens may decrease the anticoagulant activities of Fondaparinux.
Pertuzumab Injection	Pertuzumab Injection Conjugated estrogens may increase the thrombogenic activities of Pertuzumab.
Iloprost	Iloprost Conjugated estrogens may decrease the anticoagulant activities of Iloprost.
Enzalutamide	Enzalutamide The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Enzalutamide.
Mirabegron	Mirabegron Conjugated estrogens may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Regorafenib	Regorafenib Regorafenib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Corticotropin, Repository Injection	Corticotropin, Repository Injection The serum concentration of Corticotropin can be increased when it is combined with Conjugated estrogens.
Teriflunomide	Teriflunomide The serum concentration of Conjugated estrogens can be decreased when it is combined with Teriflunomide.
Teduglutide Injection	Teduglutide Injection Conjugated estrogens may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Alogliptin	Alogliptin The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Alogliptin.
Ponatinib	Ponatinib Ponatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Pomalidomide	Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Conjugated estrogens.
Ado-trastuzumab Emtansine Injection	Ado-trastuzumab Emtansine Injection Conjugated estrogens may increase the thrombogenic activities of Trastuzumab emtansine.
Apixaban	Apixaban Conjugated estrogens may decrease the anticoagulant activities of Apixaban.
Canagliflozin	Canagliflozin Conjugated estrogens may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide	Methazolamide Methazolamide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib	Dabrafenib Dabrafenib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ospemifene	Ospemifene The risk or severity of adverse effects can be increased when Conjugated estrogens is combined with Ospemifene.
Trametinib	Trametinib Conjugated estrogens may decrease the excretion rate of Trametinib which could result in a higher serum level.
Dolutegravir	Dolutegravir The excretion of Conjugated estrogens can be decreased when combined with Dolutegravir.
Afatinib	Afatinib Afatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Levomilnacipran	Levomilnacipran Conjugated estrogens may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Ertapenem Injection	Ertapenem Injection Conjugated estrogens may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Vortioxetine	Vortioxetine Conjugated estrogens may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Perampanel	Perampanel The metabolism of Perampanel can be decreased when combined with Conjugated estrogens.
Ketorolac Injection	Ketorolac Injection Ketorolac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Obinutuzumab Injection	Obinutuzumab Injection Conjugated estrogens may increase the thrombogenic activities of Obinutuzumab.
Simeprevir	Simeprevir The metabolism of Conjugated estrogens can be decreased when combined with Simeprevir.
Sofosbuvir	Sofosbuvir Conjugated estrogens may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin	Dapagliflozin The metabolism of Conjugated estrogens can be decreased when combined with Dapagliflozin.
Apremilast	Apremilast The metabolism of Conjugated estrogens can be increased when combined with Apremilast.
Droxidopa	Droxidopa Conjugated estrogens may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ramucirumab Injection	Ramucirumab Injection Conjugated estrogens may increase the thrombogenic activities of Ramucirumab.
Siltuximab Injection	Siltuximab Injection The metabolism of Conjugated estrogens can be increased when combined with Siltuximab.
Vedolizumab Injection	Vedolizumab Injection Conjugated estrogens may increase the thrombogenic activities of Vedolizumab.
Belinostat Injection	Belinostat Injection The metabolism of Conjugated estrogens can be increased when combined with Belinostat.
Idelalisib	Idelalisib The excretion of Conjugated estrogens can be decreased when combined with Idelalisib.
Testosterone Injection	Testosterone Injection Testosterone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Vorapaxar	Vorapaxar Conjugated estrogens may decrease the anticoagulant activities of Vorapaxar.
Dulaglutide Injection	Dulaglutide Injection Conjugated estrogens may increase the thrombogenic activities of Dulaglutide.
Pembrolizumab Injection	Pembrolizumab Injection Conjugated estrogens may increase the thrombogenic activities of Pembrolizumab.
Edoxaban	Edoxaban Conjugated estrogens may decrease the anticoagulant activities of Edoxaban.
Nivolumab Injection	Nivolumab Injection Conjugated estrogens may increase the thrombogenic activities of Nivolumab.
Peginterferon Beta-1a Injection	Peginterferon Beta-1a Injection The metabolism of Conjugated estrogens can be decreased when combined with Peginterferon beta-1a.
Olaparib	Olaparib Olaparib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Blinatumomab Injection	Blinatumomab Injection Conjugated estrogens may increase the thrombogenic activities of Blinatumomab.
Caspofungin Injection	Caspofungin Injection The excretion of Caspofungin can be decreased when combined with Conjugated estrogens.
Methamphetamine	Methamphetamine Conjugated estrogens may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon	Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Conjugated estrogens.
Pirfenidone	Pirfenidone The metabolism of Pirfenidone can be decreased when combined with Conjugated estrogens.
Secukinumab Injection	Secukinumab Injection The metabolism of Conjugated estrogens can be increased when combined with Secukinumab.
Palbociclib	Palbociclib Palbociclib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Insulin Human Inhalation	Insulin Human Inhalation The metabolism of Conjugated estrogens can be increased when combined with Insulin human.
Lenvatinib	Lenvatinib The metabolism of Conjugated estrogens can be decreased when combined with Lenvatinib.
Dinutuximab Injection	Dinutuximab Injection Conjugated estrogens may increase the thrombogenic activities of Dinutuximab.
Haloperidol Injection	Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Conjugated estrogens.
Amiloride	Amiloride Amiloride may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan	Macitentan Conjugated estrogens may decrease the excretion rate of Macitentan which could result in a higher serum level.
Alirocumab Injection	Alirocumab Injection Conjugated estrogens may increase the thrombogenic activities of Alirocumab.
Rolapitant	Rolapitant Rolapitant may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Prednisolone	Prednisolone The serum concentration of Prednisolone can be increased when it is combined with Conjugated estrogens.
Evolocumab Injection	Evolocumab Injection Conjugated estrogens may increase the thrombogenic activities of Evolocumab.
Daclatasvir	Daclatasvir Daclatasvir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Penicillin G Procaine Injection	Penicillin G Procaine Injection Conjugated estrogens may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline	Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Conjugated estrogens.
Insulin Degludec (rDNA Origin) Injection	Insulin Degludec (rDNA Origin) Injection The metabolism of Conjugated estrogens can be increased when combined with Insulin degludec.
Cobimetinib	Cobimetinib The excretion of Cobimetinib can be decreased when combined with Conjugated estrogens.
Mepolizumab Injection	Mepolizumab Injection Conjugated estrogens may increase the thrombogenic activities of Mepolizumab.
Elotuzumab Injection	Elotuzumab Injection Conjugated estrogens may increase the thrombogenic activities of Elotuzumab.
Daratumumab Injection	Daratumumab Injection Conjugated estrogens may increase the thrombogenic activities of Daratumumab.
Osimertinib	Osimertinib The serum concentration of Conjugated estrogens can be decreased when it is combined with Osimertinib.
Alectinib	Alectinib Alectinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ixazomib	Ixazomib Conjugated estrogens may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Necitumumab Injection	Necitumumab Injection Conjugated estrogens may increase the thrombogenic activities of Necitumumab.
Lesinurad	Lesinurad Conjugated estrogens may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection	Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Dexamethasone Injection	Dexamethasone Injection The serum concentration of Dexamethasone can be increased when it is combined with Conjugated estrogens.
Reslizumab Injection	Reslizumab Injection Conjugated estrogens may increase the thrombogenic activities of Reslizumab.
Defibrotide Injection	Defibrotide Injection Conjugated estrogens may decrease the anticoagulant activities of Defibrotide.
Ixekizumab Injection	Ixekizumab Injection Conjugated estrogens may increase the thrombogenic activities of Ixekizumab.
Brivaracetam Injection	Brivaracetam Injection Conjugated estrogens may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Venetoclax	Venetoclax Venetoclax may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cobicistat	Cobicistat Cobicistat may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Selexipag	Selexipag The excretion of Selexipag can be decreased when combined with Conjugated estrogens.
Obeticholic Acid	Obeticholic Acid The metabolism of Conjugated estrogens can be decreased when combined with Obeticholic acid.
Atezolizumab Injection	Atezolizumab Injection Conjugated estrogens may increase the thrombogenic activities of Atezolizumab.
Furosemide Injection	Furosemide Injection The therapeutic efficacy of Furosemide can be decreased when used in combination with Conjugated estrogens.
Olaratumab Injection	Olaratumab Injection Conjugated estrogens may increase the thrombogenic activities of Olaratumab.
Rucaparib	Rucaparib The excretion of Conjugated estrogens can be decreased when combined with Rucaparib.
Bezlotoxumab Injection	Bezlotoxumab Injection Conjugated estrogens may increase the thrombogenic activities of Bezlotoxumab.
Lixisenatide Injection	Lixisenatide Injection Conjugated estrogens may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Avelumab Injection	Avelumab Injection Conjugated estrogens may increase the thrombogenic activities of Avelumab.
Brodalumab Injection	Brodalumab Injection Conjugated estrogens may increase the thrombogenic activities of Brodalumab.
Brigatinib	Brigatinib Brigatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Doxepin (Insomnia)	Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Conjugated estrogens.
Dupilumab Injection	Dupilumab Injection Conjugated estrogens may increase the thrombogenic activities of Dupilumab.
Deutetrabenazine	Deutetrabenazine Conjugated estrogens may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine	Valbenazine Conjugated estrogens may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort	Deflazacort The serum concentration of Deflazacort can be increased when it is combined with Conjugated estrogens.
Safinamide	Safinamide Safinamide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ocrelizumab Injection	Ocrelizumab Injection Conjugated estrogens may increase the thrombogenic activities of Ocrelizumab.
Edaravone Injection	Edaravone Injection The excretion of Edaravone can be decreased when combined with Conjugated estrogens.
Durvalumab Injection	Durvalumab Injection Conjugated estrogens may increase the thrombogenic activities of Durvalumab.
Naldemedine	Naldemedine Conjugated estrogens may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection	Sarilumab Injection Conjugated estrogens may increase the thrombogenic activities of Sarilumab.
Midostaurin	Midostaurin The metabolism of Conjugated estrogens can be decreased when combined with Midostaurin.
Guselkumab Injection	Guselkumab Injection Conjugated estrogens may increase the thrombogenic activities of Guselkumab.
Enasidenib	Enasidenib The metabolism of Conjugated estrogens can be decreased when combined with Enasidenib.
Inotuzumab Ozogamicin Injection	Inotuzumab Ozogamicin Injection Conjugated estrogens may increase the thrombogenic activities of Inotuzumab ozogamicin.
Benznidazole	Benznidazole Conjugated estrogens may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin	Delafloxacin Conjugated estrogens may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Abemaciclib	Abemaciclib Abemaciclib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Betrixaban	Betrixaban Conjugated estrogens may decrease the anticoagulant activities of Betrixaban.
Benralizumab Injection	Benralizumab Injection Conjugated estrogens may increase the thrombogenic activities of Benralizumab.
Gemtuzumab Ozogamicin Injection	Gemtuzumab Ozogamicin Injection Conjugated estrogens may increase the thrombogenic activities of Gemtuzumab ozogamicin.
Letermovir	Letermovir The excretion of Conjugated estrogens can be decreased when combined with Letermovir.
Ertugliflozin	Ertugliflozin Ertugliflozin may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection	Buprenorphine Injection Buprenorphine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Apalutamide	Apalutamide The excretion of Conjugated estrogens can be decreased when combined with Apalutamide.
Ibalizumab-uiyk Injection	Ibalizumab-uiyk Injection Conjugated estrogens may increase the thrombogenic activities of Ibalizumab.
Penicillamine	Penicillamine The excretion of Penicillamine can be decreased when combined with Conjugated estrogens.
Fostamatinib	Fostamatinib Fostamatinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Tildrakizumab-asmn injection	Tildrakizumab-asmn injection Conjugated estrogens may increase the thrombogenic activities of Tildrakizumab.
Erenumab-aooe Injection	Erenumab-aooe Injection Conjugated estrogens may increase the thrombogenic activities of Erenumab.
Avatrombopag	Avatrombopag Avatrombopag may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Baricitinib	Baricitinib Baricitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Burosumab-twza Injection	Burosumab-twza Injection Conjugated estrogens may increase the thrombogenic activities of Burosumab.
Lofexidine	Lofexidine The metabolism of Lofexidine can be decreased when combined with Conjugated estrogens.
Plazomicin Injection	Plazomicin Injection Conjugated estrogens may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Binimetinib	Binimetinib The metabolism of Binimetinib can be decreased when combined with Conjugated estrogens.
Ivosidenib	Ivosidenib The excretion of Conjugated estrogens can be decreased when combined with Ivosidenib.
Elagolix	Elagolix The excretion of Elagolix can be decreased when combined with Conjugated estrogens.
Cannabidiol	Cannabidiol Cannabidiol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cemiplimab-rwlc Injection	Cemiplimab-rwlc Injection Conjugated estrogens may increase the thrombogenic activities of Cemiplimab.
Dacomitinib	Dacomitinib Dacomitinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Galcanezumab-gnlm Injection	Galcanezumab-gnlm Injection Conjugated estrogens may increase the thrombogenic activities of Galcanezumab.
Mogamulizumab-kpkc Injection	Mogamulizumab-kpkc Injection Conjugated estrogens may increase the thrombogenic activities of Mogamulizumab.
Stiripentol	Stiripentol The metabolism of Conjugated estrogens can be decreased when combined with Stiripentol.
Gilteritinib	Gilteritinib Gilteritinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Glasdegib	Glasdegib Glasdegib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Rifamycin	Rifamycin The metabolism of Conjugated estrogens can be decreased when combined with Rifamycin.
Prucalopride	Prucalopride Conjugated estrogens may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Ravulizumab-cwvz Injection	Ravulizumab-cwvz Injection Conjugated estrogens may increase the thrombogenic activities of Ravulizumab.
Emapalumab-lzsg Injection	Emapalumab-lzsg Injection The metabolism of Conjugated estrogens can be increased when combined with Emapalumab.
Romosozumab-aqqg Injection	Romosozumab-aqqg Injection Conjugated estrogens may increase the thrombogenic activities of Romosozumab.
Acyclovir Ophthalmic	Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Caplacizumab-yhdp Injection	Caplacizumab-yhdp Injection Conjugated estrogens may increase the thrombogenic activities of Caplacizumab.
Esomeprazole Injection	Esomeprazole Injection The excretion of Conjugated estrogens can be decreased when combined with Esomeprazole.
Risankizumab-rzaa Injection	Risankizumab-rzaa Injection Conjugated estrogens may increase the thrombogenic activities of Risankizumab.
Polatuzumab vedotin-piiq Injection	Polatuzumab vedotin-piiq Injection Conjugated estrogens may increase the thrombogenic activities of Polatuzumab vedotin.
Solriamfetol	Solriamfetol Conjugated estrogens may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Selinexor	Selinexor The excretion of Conjugated estrogens can be decreased when combined with Selinexor.
Darolutamide	Darolutamide The serum concentration of Conjugated estrogens can be increased when it is combined with Darolutamide.
Triclabendazole	Triclabendazole The metabolism of Conjugated estrogens can be decreased when combined with Triclabendazole.
Pexidartinib	Pexidartinib The excretion of Conjugated estrogens can be decreased when combined with Pexidartinib.
Istradefylline	Istradefylline The metabolism of Istradefylline can be decreased when combined with Conjugated estrogens.
Pitolisant	Pitolisant The serum concentration of Conjugated estrogens can be decreased when it is combined with Pitolisant.
Fedratinib	Fedratinib Fedratinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Phenytoin Injection	Phenytoin Injection The therapeutic efficacy of Phenytoin can be decreased when used in combination with Conjugated estrogens.
Fosphenytoin Injection	Fosphenytoin Injection The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Fosphenytoin.
Brolucizumab-dbll Injection	Brolucizumab-dbll Injection Conjugated estrogens may increase the thrombogenic activities of Brolucizumab.
Fam-trastuzumab deruxtecan-nxki Injection	Fam-trastuzumab deruxtecan-nxki Injection Conjugated estrogens may increase the thrombogenic activities of Trastuzumab deruxtecan.
Lasmiditan	Lasmiditan The serum concentration of Conjugated estrogens can be increased when it is combined with Lasmiditan.
Bempedoic Acid	Bempedoic Acid The excretion of Conjugated estrogens can be decreased when combined with Bempedoic acid.
Cenobamate	Cenobamate The serum concentration of Conjugated estrogens can be decreased when it is combined with Cenobamate.
Isatuximab-irfc Injection	Isatuximab-irfc Injection Conjugated estrogens may increase the thrombogenic activities of Isatuximab.
Teprotumumab-trbw Injection	Teprotumumab-trbw Injection Conjugated estrogens may increase the thrombogenic activities of Teprotumumab.
Selumetinib	Selumetinib The metabolism of Selumetinib can be decreased when combined with Conjugated estrogens.
Tucatinib	Tucatinib The metabolism of Tucatinib can be decreased when combined with Conjugated estrogens.
Remdesivir Injection	Remdesivir Injection The excretion of Remdesivir can be decreased when combined with Conjugated estrogens.
Sacituzumab govitecan-hziy Injection	Sacituzumab govitecan-hziy Injection Conjugated estrogens may increase the thrombogenic activities of Sacituzumab govitecan.
Ripretinib	Ripretinib Ripretinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Capmatinib	Capmatinib The serum concentration of Conjugated estrogens can be increased when it is combined with Capmatinib.
Daratumumab and Hyaluronidase-fihj Injection	Daratumumab and Hyaluronidase-fihj Injection The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Conjugated estrogens.
Luspatercept-aamt Injection	Luspatercept-aamt Injection Conjugated estrogens may increase the thrombogenic activities of Luspatercept.
Fostemsavir	Fostemsavir Fostemsavir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection	Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf Injection The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Conjugated estrogens.
Belantamab Mafodotin-blmf Injection	Belantamab Mafodotin-blmf Injection Conjugated estrogens may increase the thrombogenic activities of Belantamab mafodotin.
Tafasitamab-cxix Injection	Tafasitamab-cxix Injection Conjugated estrogens may increase the thrombogenic activities of Tafasitamab.
Pralsetinib	Pralsetinib Pralsetinib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Opicapone	Opicapone The metabolism of Conjugated estrogens can be decreased when combined with Opicapone.
Satralizumab-mwge Injection	Satralizumab-mwge Injection The serum concentration of Conjugated estrogens can be decreased when it is combined with Satralizumab.
Margetuximab-cmkb Injection	Margetuximab-cmkb Injection Conjugated estrogens may increase the thrombogenic activities of Margetuximab.
Cabotegravir	Cabotegravir The excretion of Conjugated estrogens can be decreased when combined with Cabotegravir.
Progestin-Only (drospirenone) Oral Contraceptives	Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Evinacumab-dgnb Injection	Evinacumab-dgnb Injection Conjugated estrogens may increase the thrombogenic activities of Evinacumab.
Viloxazine	Viloxazine Conjugated estrogens may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Aducanumab-avwa Injection	Aducanumab-avwa Injection Conjugated estrogens may increase the thrombogenic activities of Aducanumab.
Anifrolumab-fnia Injection	Anifrolumab-fnia Injection Conjugated estrogens may increase the thrombogenic activities of Anifrolumab.
Tobramycin Injection	Tobramycin Injection Tobramycin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Theophylline	Theophylline The metabolism of Theophylline can be decreased when combined with Conjugated estrogens.
Fenoprofen	Fenoprofen Fenoprofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Indomethacin	Indomethacin The excretion of Conjugated estrogens can be decreased when combined with Indomethacin.
Mefenamic Acid	Mefenamic Acid Mefenamic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Naproxen	Naproxen Naproxen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Tolmetin	Tolmetin Tolmetin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Sulindac	Sulindac Sulindac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Isotretinoin	Isotretinoin Conjugated estrogens may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate	Sucralfate Conjugated estrogens may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Floxuridine	Floxuridine Conjugated estrogens may decrease the excretion rate of Floxuridine which could result in a higher serum level.
Metaxalone	Metaxalone Conjugated estrogens may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection	Methotrexate Injection Methotrexate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Primidone	Primidone The metabolism of Conjugated estrogens can be increased when combined with Primidone.
Chlorpromazine	Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Conjugated estrogens.
Diazepam	Diazepam Conjugated estrogens may decrease the excretion rate of Diazepam which could result in a higher serum level.
Oxazepam	Oxazepam Conjugated estrogens may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam	Flurazepam Conjugated estrogens may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate	Clorazepate Conjugated estrogens may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam	Lorazepam Lorazepam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Carmustine	Carmustine The metabolism of Conjugated estrogens can be decreased when combined with Carmustine.
Amantadine	Amantadine Conjugated estrogens may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine	Codeine Conjugated estrogens may decrease the excretion rate of Codeine which could result in a higher serum level.
Tranylcypromine	Tranylcypromine The metabolism of Conjugated estrogens can be decreased when combined with Tranylcypromine.
Phenelzine	Phenelzine Conjugated estrogens may decrease the excretion rate of Phenelzine which could result in a higher serum level.
Tetracycline	Tetracycline The excretion of Tetracycline can be decreased when combined with Conjugated estrogens.
Minocycline	Minocycline The excretion of Conjugated estrogens can be decreased when combined with Minocycline.
Trifluoperazine	Trifluoperazine The metabolism of Trifluoperazine can be decreased when combined with Conjugated estrogens.
Bleomycin	Bleomycin Conjugated estrogens may decrease the excretion rate of Bleomycin which could result in a higher serum level.
Sulfadiazine	Sulfadiazine Conjugated estrogens may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
Benztropine	Benztropine Benzatropine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Maprotiline	Maprotiline The metabolism of Maprotiline can be decreased when combined with Conjugated estrogens.
Ibuprofen	Ibuprofen The excretion of Conjugated estrogens can be decreased when combined with Ibuprofen.
Orphenadrine	Orphenadrine The metabolism of Conjugated estrogens can be decreased when combined with Orphenadrine.
Perphenazine	Perphenazine The metabolism of Perphenazine can be decreased when combined with Conjugated estrogens.
Azathioprine	Azathioprine The metabolism of Azathioprine can be decreased when combined with Conjugated estrogens.
Methylphenidate	Methylphenidate Conjugated estrogens may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
Amoxapine	Amoxapine The serum concentration of Amoxapine can be increased when it is combined with Conjugated estrogens.
Sulfasalazine	Sulfasalazine Sulfasalazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Hydrocortisone	Hydrocortisone The serum concentration of Hydrocortisone can be increased when it is combined with Conjugated estrogens.
Phenazopyridine	Phenazopyridine Phenazopyridine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Carbamazepine	Carbamazepine The metabolism of Conjugated estrogens can be increased when combined with Carbamazepine.
Methyldopa	Methyldopa Conjugated estrogens may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine	Clonidine The metabolism of Clonidine can be decreased when combined with Conjugated estrogens.
Hydralazine	Hydralazine Conjugated estrogens may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine	Cimetidine The excretion of Cimetidine can be decreased when combined with Conjugated estrogens.
Gentamicin Injection	Gentamicin Injection Gentamicin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Warfarin	Warfarin The metabolism of Warfarin can be decreased when combined with Conjugated estrogens.
Clonazepam	Clonazepam Conjugated estrogens may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Promethazine	Promethazine Conjugated estrogens may decrease the excretion rate of Promethazine which could result in a higher serum level.
Meclofenamate	Meclofenamate The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Meclofenamic acid.
Nitrofurantoin	Nitrofurantoin The therapeutic efficacy of Nitrofurantoin can be decreased when used in combination with Conjugated estrogens.
Griseofulvin	Griseofulvin The metabolism of Conjugated estrogens can be increased when combined with Griseofulvin.
Digoxin	Digoxin Conjugated estrogens may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine	Chloroquine Conjugated estrogens may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Quinine	Quinine The metabolism of Conjugated estrogens can be decreased when combined with Quinine.
Triamterene	Triamterene The metabolism of Triamterene can be decreased when combined with Conjugated estrogens.
Chlorothiazide	Chlorothiazide Chlorothiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone	Chlorthalidone Chlorthalidone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone	Metolazone Conjugated estrogens may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide	Isosorbide Isosorbide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital	Secobarbital The metabolism of Secobarbital can be increased when combined with Conjugated estrogens.
Desipramine	Desipramine Conjugated estrogens may decrease the excretion rate of Desipramine which could result in a higher serum level.
Amitriptyline	Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Conjugated estrogens.
Imipramine	Imipramine The metabolism of Conjugated estrogens can be decreased when combined with Imipramine.
Probenecid	Probenecid The excretion of Conjugated estrogens can be decreased when combined with Probenecid.
Quinidine	Quinidine The metabolism of Quinidine can be decreased when combined with Conjugated estrogens.
Procainamide	Procainamide Conjugated estrogens may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid	Isoniazid The metabolism of Isoniazid can be decreased when combined with Conjugated estrogens.
Pyrazinamide	Pyrazinamide Conjugated estrogens may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
Rifampin	Rifampin The metabolism of Conjugated estrogens can be increased when combined with Rifampicin.
Disopyramide	Disopyramide The metabolism of Conjugated estrogens can be decreased when combined with Disopyramide.
Valproic Acid	Valproic Acid The excretion of Valproic acid can be decreased when combined with Conjugated estrogens.
Tamoxifen	Tamoxifen The metabolism of Tamoxifen can be decreased when combined with Conjugated estrogens.
Butabarbital	Butabarbital Butabarbital may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Levothyroxine	Levothyroxine The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Conjugated estrogens.
Liothyronine	Liothyronine The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Liothyronine.
Methimazole	Methimazole The metabolism of Conjugated estrogens can be decreased when combined with Methimazole.
Chlorpropamide	Chlorpropamide The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Conjugated estrogens.
Tolbutamide	Tolbutamide The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Conjugated estrogens.
Tolazamide	Tolazamide The therapeutic efficacy of Tolazamide can be decreased when used in combination with Conjugated estrogens.
Dinoprostone	Dinoprostone The excretion of Dinoprostone can be decreased when combined with Conjugated estrogens.
Cyclobenzaprine	Cyclobenzaprine The metabolism of Cyclobenzaprine can be decreased when combined with Conjugated estrogens.
Baclofen	Baclofen Baclofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ethambutol	Ethambutol Conjugated estrogens may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Methyclothiazide	Methyclothiazide Methyclothiazide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide	Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Dantrolene	Dantrolene The therapeutic efficacy of Dantrolene can be decreased when used in combination with Conjugated estrogens.
Chlorzoxazone	Chlorzoxazone The metabolism of Chlorzoxazone can be decreased when combined with Conjugated estrogens.
Pyridoxine	Pyridoxine Pyridoxine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Folic Acid	Folic Acid Folic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Propranolol (Cardiovascular)	Propranolol (Cardiovascular) The metabolism of Propranolol can be decreased when combined with Conjugated estrogens.
Nortriptyline	Nortriptyline The serum concentration of Nortriptyline can be increased when it is combined with Conjugated estrogens.
Spironolactone	Spironolactone Spironolactone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection	Amphotericin B Injection Amphotericin B may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Mercaptopurine	Mercaptopurine The excretion of Mercaptopurine can be decreased when combined with Conjugated estrogens.
Phytonadione	Phytonadione Conjugated estrogens may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection	Amikacin Injection Amikacin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Nadolol	Nadolol Conjugated estrogens may decrease the excretion rate of Nadolol which could result in a higher serum level.
Allopurinol	Allopurinol The excretion of Allopurinol can be decreased when combined with Conjugated estrogens.
Flavoxate	Flavoxate Conjugated estrogens may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Fluorouracil Injection	Fluorouracil Injection The metabolism of Fluorouracil can be decreased when combined with Conjugated estrogens.
Colchicine	Colchicine Conjugated estrogens may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor	Cefaclor Cefaclor may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefadroxil	Cefadroxil Cefadroxil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefazolin Injection	Cefazolin Injection Cefazolin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cephalexin	Cephalexin Cephalexin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefoxitin Injection	Cefoxitin Injection Cefoxitin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Dacarbazine	Dacarbazine The metabolism of Dacarbazine can be decreased when combined with Conjugated estrogens.
Acetazolamide	Acetazolamide Acetazolamide may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy.
Nystatin	Nystatin The excretion of Conjugated estrogens can be decreased when combined with Nystatin.
Cefotaxime Injection	Cefotaxime Injection Cefotaxime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Calcitonin Salmon Injection	Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ketoconazole	Ketoconazole The metabolism of Conjugated estrogens can be decreased when combined with Ketoconazole.
Pyrantel	Pyrantel Conjugated estrogens may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Vincristine Injection	Vincristine Injection The excretion of Conjugated estrogens can be decreased when combined with Vincristine.
Captopril	Captopril The excretion of Captopril can be decreased when combined with Conjugated estrogens.
Dipyridamole	Dipyridamole Conjugated estrogens may decrease the anticoagulant activities of Dipyridamole.
Vinblastine	Vinblastine The excretion of Conjugated estrogens can be decreased when combined with Vinblastine.
Ethacrynic Acid	Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Colistimethate Injection	Colistimethate Injection Colistimethate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Metoprolol	Metoprolol Metoprolol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Thiothixene	Thiothixene The metabolism of Thiothixene can be decreased when combined with Conjugated estrogens.
Aspirin	Aspirin Conjugated estrogens may decrease the anticoagulant activities of Acetylsalicylic acid.
Salsalate	Salsalate Salsalate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Alprazolam	Alprazolam Conjugated estrogens may decrease the excretion rate of Alprazolam which could result in a higher serum level.
Temazepam	Temazepam Temazepam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Triazolam	Triazolam Conjugated estrogens may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine	Dicyclomine Conjugated estrogens may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline	Propantheline Conjugated estrogens may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim	Trimethoprim Conjugated estrogens may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
Nifedipine	Nifedipine The metabolism of Conjugated estrogens can be decreased when combined with Nifedipine.
Timolol	Timolol Conjugated estrogens may decrease the excretion rate of Timolol which could result in a higher serum level.
Verapamil	Verapamil The metabolism of Conjugated estrogens can be decreased when combined with Verapamil.
Pindolol	Pindolol Conjugated estrogens may decrease the excretion rate of Pindolol which could result in a higher serum level.
Cisplatin Injection	Cisplatin Injection Conjugated estrogens may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal	Diflunisal Diflunisal may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Piroxicam	Piroxicam Piroxicam may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Bumetanide	Bumetanide Conjugated estrogens may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
Streptozocin	Streptozocin The metabolism of Conjugated estrogens can be increased when combined with Streptozocin.
Etoposide	Etoposide The metabolism of Etoposide can be decreased when combined with Conjugated estrogens.
Glyburide	Glyburide The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Glyburide.
Glipizide	Glipizide The therapeutic efficacy of Glipizide can be decreased when used in combination with Conjugated estrogens.
Indapamide	Indapamide Conjugated estrogens may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin	Amoxicillin Conjugated estrogens may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Nafcillin Injection	Nafcillin Injection The metabolism of Conjugated estrogens can be increased when combined with Nafcillin.
Oxacillin Injection	Oxacillin Injection Conjugated estrogens may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline	Pentoxifylline The metabolism of Pentoxifylline can be decreased when combined with Conjugated estrogens.
Pentamidine Injection	Pentamidine Injection Pentamidine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ceftriaxone Injection	Ceftriaxone Injection The excretion of Conjugated estrogens can be decreased when combined with Ceftriaxone.
Labetalol	Labetalol Conjugated estrogens may decrease the excretion rate of Labetalol which could result in a higher serum level.
Auranofin	Auranofin Conjugated estrogens may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection	Leuprolide Injection Leuprolide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Gemfibrozil	Gemfibrozil The metabolism of Conjugated estrogens can be decreased when combined with Gemfibrozil.
Guanabenz	Guanabenz The metabolism of Guanabenz can be decreased when combined with Conjugated estrogens.
Dipivefrin Ophthalmic	Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ceftazidime Injection	Ceftazidime Injection Ceftazidime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Ketoprofen	Ketoprofen Ketoprofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefotetan Injection	Cefotetan Injection Cefotetan may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Pimozide	Pimozide The metabolism of Pimozide can be decreased when combined with Conjugated estrogens.
Enalapril	Enalapril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Enalapril.
Flurbiprofen	Flurbiprofen Flurbiprofen may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Amiodarone	Amiodarone The metabolism of Amiodarone can be decreased when combined with Conjugated estrogens.
Aztreonam Injection	Aztreonam Injection Conjugated estrogens may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone	Buspirone Conjugated estrogens may decrease the excretion rate of Buspirone which could result in a higher serum level.
Lovastatin	Lovastatin The excretion of Conjugated estrogens can be decreased when combined with Lovastatin.
Ciprofloxacin	Ciprofloxacin The metabolism of Conjugated estrogens can be decreased when combined with Ciprofloxacin.
Mesalamine	Mesalamine Mesalazine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Diclofenac	Diclofenac Diclofenac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fluoxetine	Fluoxetine The metabolism of Fluoxetine can be decreased when combined with Conjugated estrogens.
Interferon Alfa-2b Injection	Interferon Alfa-2b Injection The metabolism of Conjugated estrogens can be decreased when combined with Interferon alfa-2b.
Clozapine	Clozapine The metabolism of Clozapine can be decreased when combined with Conjugated estrogens.
Estazolam	Estazolam Conjugated estrogens may decrease the excretion rate of Estazolam which could result in a higher serum level.
Ofloxacin	Ofloxacin The metabolism of Conjugated estrogens can be decreased when combined with Ofloxacin.
Didanosine	Didanosine Conjugated estrogens may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection	Pentostatin Injection Conjugated estrogens may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Benazepril	Benazepril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Benazepril.
Etodolac	Etodolac Etodolac may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fosinopril	Fosinopril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Fosinopril.
Nabumetone	Nabumetone Nabumetone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Pravastatin	Pravastatin Pravastatin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Quinapril	Quinapril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Quinapril.
Ramipril	Ramipril The risk or severity of angioedema can be increased when Ramipril is combined with Conjugated estrogens.
Simvastatin	Simvastatin The excretion of Simvastatin can be decreased when combined with Conjugated estrogens.
Lisinopril	Lisinopril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Lisinopril.
Oxaprozin	Oxaprozin Oxaprozin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Bisoprolol	Bisoprolol Conjugated estrogens may decrease the excretion rate of Bisoprolol which could result in a higher serum level.
Zolpidem	Zolpidem The metabolism of Zolpidem can be decreased when combined with Conjugated estrogens.
Isradipine	Isradipine Isradipine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Omeprazole	Omeprazole Omeprazole may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fluvastatin	Fluvastatin The excretion of Conjugated estrogens can be decreased when combined with Fluvastatin.
Venlafaxine	Venlafaxine Venlafaxine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fluvoxamine	Fluvoxamine The metabolism of Conjugated estrogens can be decreased when combined with Fluvoxamine.
Nefazodone	Nefazodone Nefazodone may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Lamotrigine	Lamotrigine The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Conjugated estrogens.
Losartan	Losartan The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Losartan.
Valacyclovir	Valacyclovir Valaciclovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Tramadol	Tramadol Tramadol may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Carboplatin Injection	Carboplatin Injection Carboplatin may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Moexipril	Moexipril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Moexipril.
Lansoprazole	Lansoprazole The excretion of Conjugated estrogens can be decreased when combined with Lansoprazole.
Alprostadil Urogenital	Alprostadil Urogenital The excretion of Alprostadil can be decreased when combined with Conjugated estrogens.
Ifosfamide Injection	Ifosfamide Injection Conjugated estrogens may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
Nicardipine	Nicardipine The excretion of Conjugated estrogens can be decreased when combined with Nicardipine.
Bupropion	Bupropion Conjugated estrogens may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine	Ticlopidine The metabolism of Conjugated estrogens can be decreased when combined with Ticlopidine.
Saquinavir	Saquinavir Saquinavir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Metformin	Metformin Conjugated estrogens may decrease the excretion rate of Metformin which could result in a higher serum level.
Dalteparin Injection	Dalteparin Injection Conjugated estrogens may decrease the anticoagulant activities of Dalteparin.
Nisoldipine	Nisoldipine Conjugated estrogens may decrease the excretion rate of Nisoldipine which could result in a higher serum level.
Lamivudine	Lamivudine Conjugated estrogens may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Riluzole	Riluzole The metabolism of Riluzole can be decreased when combined with Conjugated estrogens.
Acarbose	Acarbose Acarbose may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Glimepiride	Glimepiride The therapeutic efficacy of Glimepiride can be decreased when used in combination with Conjugated estrogens.
Anastrozole	Anastrozole The therapeutic efficacy of Anastrozole can be decreased when used in combination with Conjugated estrogens.
Gemcitabine Injection	Gemcitabine Injection Conjugated estrogens may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Indinavir	Indinavir The excretion of Conjugated estrogens can be decreased when combined with Indinavir.
Ritonavir	Ritonavir The serum concentration of Ritonavir can be increased when it is combined with Conjugated estrogens.
Cidofovir Injection	Cidofovir Injection Cidofovir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Meropenem Injection	Meropenem Injection Conjugated estrogens may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine	Clomipramine The metabolism of Clomipramine can be decreased when combined with Conjugated estrogens.
Zafirlukast	Zafirlukast The metabolism of Conjugated estrogens can be decreased when combined with Zafirlukast.
Fosfomycin	Fosfomycin Conjugated estrogens may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine	Mirtazapine The metabolism of Mirtazapine can be decreased when combined with Conjugated estrogens.
Trandolapril	Trandolapril The risk or severity of angioedema can be increased when Conjugated estrogens is combined with Trandolapril.
Topiramate	Topiramate Topiramate may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Zileuton	Zileuton The metabolism of Zileuton can be decreased when combined with Conjugated estrogens.
Valsartan	Valsartan The risk or severity of angioedema can be increased when Valsartan is combined with Conjugated estrogens.
Insulin Lispro Injection	Insulin Lispro Injection The metabolism of Conjugated estrogens can be increased when combined with Insulin lispro.
Pramipexole	Pramipexole Conjugated estrogens may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Nelfinavir	Nelfinavir Nelfinavir may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fexofenadine	Fexofenadine The excretion of Fexofenadine can be decreased when combined with Conjugated estrogens.
Carvedilol	Carvedilol The metabolism of Carvedilol can be decreased when combined with Conjugated estrogens.
Nilutamide	Nilutamide Conjugated estrogens may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide	Flutamide The metabolism of Flutamide can be decreased when combined with Conjugated estrogens.
Selegiline	Selegiline The metabolism of Selegiline can be decreased when combined with Conjugated estrogens.
Propafenone	Propafenone The metabolism of Propafenone can be decreased when combined with Conjugated estrogens.
Raloxifene	Raloxifene The excretion of Raloxifene can be decreased when combined with Conjugated estrogens.
Tamsulosin	Tamsulosin Conjugated estrogens may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Ropinirole	Ropinirole The risk or severity of adverse effects can be increased when Conjugated estrogens is combined with Ropinirole.
Quetiapine	Quetiapine Conjugated estrogens may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection	Cefepime Injection Cefepime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefprozil	Cefprozil Cefprozil may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cefpodoxime	Cefpodoxime Cefpodoxime may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Cetirizine	Cetirizine Conjugated estrogens may decrease the excretion rate of Cetirizine which could result in a higher serum level.
Paroxetine	Paroxetine The metabolism of Paroxetine can be decreased when combined with Conjugated estrogens.
Palivizumab Injection	Palivizumab Injection Conjugated estrogens may increase the thrombogenic activities of Palivizumab.
Tolcapone	Tolcapone Conjugated estrogens may decrease the excretion rate of Tolcapone which could result in a higher serum level.
Citalopram	Citalopram The metabolism of Conjugated estrogens can be decreased when combined with Citalopram.
Capecitabine	Capecitabine Conjugated estrogens may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Efavirenz	Efavirenz The metabolism of Conjugated estrogens can be decreased when combined with Efavirenz.
Abacavir	Abacavir Conjugated estrogens may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil	Sildenafil The excretion of Conjugated estrogens can be decreased when combined with Sildenafil.
Trastuzumab Injection	Trastuzumab Injection Conjugated estrogens may increase the thrombogenic activities of Trastuzumab.
Celecoxib	Celecoxib Celecoxib may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Rosiglitazone	Rosiglitazone The metabolism of Conjugated estrogens can be decreased when combined with Rosiglitazone.
Tolterodine	Tolterodine Conjugated estrogens may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide	Thalidomide Conjugated estrogens may increase the thrombogenic activities of Thalidomide.
Oseltamivir	Oseltamivir The excretion of Conjugated estrogens can be decreased when combined with Oseltamivir.
Balsalazide	Balsalazide Balsalazide may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Nateglinide	Nateglinide Conjugated estrogens may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Rabeprazole	Rabeprazole Rabeprazole may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Terbinafine	Terbinafine The metabolism of Terbinafine can be decreased when combined with Conjugated estrogens.